These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 588399)

  • 1. Changes in myocardial performance induced by pancuronium and gallamine in hypercapnic and hypocapnic dogs.
    Eriksen S; Hommelgård P; Videbaek J
    Br J Anaesth; 1977 Dec; 49(12):1199-1206. PubMed ID: 588399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of gallamine, pancuronium, d-tubocurarine and succinylcholine on adrenergic neurotransmission.
    Vercruysse P; Bossuyt P; Verbeuren TJ; Vanhoutte PM; Hanegreefs G
    Acta Anaesthesiol Belg; 1979; 30 Suppl():71-8. PubMed ID: 232807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallamine and pancuronium inhibit pre- and postjunctional muscarine receptors in canine saphenous veins.
    Vercruysse P; Bossuyt P; Hanegreefs G; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1979 May; 209(2):225-30. PubMed ID: 438998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the neuromuscular blocking action of gallamine and pancuronium and their reversal by neostigmine.
    Gleed RD; Jones RS
    Res Vet Sci; 1982 May; 32(3):324-6. PubMed ID: 7100648
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct evidence that pancuronium and gallamine enhance the release of norepinephrine from the atrial sympathetic nerve by inhibiting prejunctional muscarinic receptors.
    Kobayashi O; Nagashima H; Duncalf D; Chaudhry IA; Harsing LG; Foldes FF; Goldiner PL; Vizi ES
    J Auton Nerv Syst; 1987 Jan; 18(1):55-60. PubMed ID: 2880888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of pancuronium bromide and gallamine triethiodide during barbiturate, N 2 O--halothane anaesthesia.
    Kölliker K
    Acta Anaesthesiol Scand; 1972; 16(4):240-5. PubMed ID: 4265584
    [No Abstract]   [Full Text] [Related]  

  • 8. Cumulative dose responses to gallamine, pancuronium, and neostigmine in halothane-anesthetized horses: neuromuscular and cardiovascular effects.
    Klein L; Hopkins J; Beck E; Burton B
    Am J Vet Res; 1983 May; 44(5):786-92. PubMed ID: 6869984
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of hypocapnia and hypocapnic alkalosis on cardiovascular function.
    Zwillich CW; Pierson DJ; Creagh EM; Weil JV
    J Appl Physiol; 1976 Mar; 40(3):333-7. PubMed ID: 931846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diazepam on neuromuscular transmission and its interaction with non-depolarizing muscle relaxants.
    Jain PD; Pandey K; De M
    Anaesth Intensive Care; 1976 May; 4(2):122-5. PubMed ID: 937720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of gallamine and pancuronium with tubocurarine under morphine-nitrous oxide-oxygen anesthesia in man.
    Park WY; Balingit PE; Macnamara TE
    Anesth Analg; 1974; 53(5):723-9. PubMed ID: 4472154
    [No Abstract]   [Full Text] [Related]  

  • 13. Thiopentone-nitrous oxide-halothane anaesthesia and suxamethonium: pretreatment with pancuronium and gallamine.
    Jørgensen BC; Eikard B; Rasmussen JP; Viby-Mogensen J
    Br J Anaesth; 1980 Dec; 52(12):1277-81. PubMed ID: 7448103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of beta-receptor blockade and PCO2 levles in the anaesthetized dog.
    Foex P; Prys-Roberts C
    Br J Anaesth; 1974 Jun; 46(6):397-404. PubMed ID: 4156480
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of pancuronium and gallamine on muscarinic transmission in the superior cervical ganglion.
    Gardier RW; Tsevdos EJ; Jackson DB
    J Pharmacol Exp Ther; 1978 Jan; 204(1):46-53. PubMed ID: 201745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prior administration of a non-depolarising muscle relaxant on the action of suxamethonium in the dog.
    Jones RS; Gleed RD
    Res Vet Sci; 1984 May; 36(3):348-53. PubMed ID: 6463378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM; Forde SC; Appadu BL; Lambert DG
    Eur J Pharmacol; 2007 Aug; 569(1-2):37-40. PubMed ID: 17588565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential blocking effects of atropine and gallamine on negative chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
    Furukawa Y; Wallick DW; Martin P
    J Pharmacol Exp Ther; 1989 Dec; 251(3):797-802. PubMed ID: 2600814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of myoneural blockers on intracranial dynamics.
    Weiss MH; Wertman N; Apuzzo ML; Heiden JS; Kurze T
    Bull Los Angeles Neurol Soc; 1977 Mar; 42(1):1-7. PubMed ID: 76491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.